Incomplete Brown-Séquard syndrome secondary to acenocoumarol-induced hematomyelia: A case report

Table 1 Laboratory findings

Laboratory panel	Result
Coagulation panel
PT (%)	30
INR	2.6
Thyroid panel
TSH (mU/L)	0.418
FT3 (pg/mL)	1.83
FT4 (ng/dL)	1.3
Anti-TPO (IU/mL)	3
Infectious panel
HIV 1/2	Negative
HBsAg	0.32 S/CO (negative)
Anti-HCV	0.66 S/CO (negative)
Protein electrophoresis
Albumin (%)	56.5
α1-globulins (%)	3.6
α2-globulins (%)	14.4
β1-globulins (%)	6.5
β2-globulins (%)	7.7
γ-globulins (%)	11.3
A/G ratio	1.3
Autoimmune panel
ANA	< 1:160
Anti-dsDNA (IU/mL)	8.6
MPO (RU/mL)	1.5
RF (IU/mL)	< 20
Tumor markers
CEA (ng/mL)	2
AFP (ng/mL)	4
CA-125 (U/mL)	11.8
CA-19-9 (U/mL)	< 2.06
CA-15-3 (U/mL)	13

PT: Prothrombin time; INR: International normalized ratio; FT3: Free triiodothyronine; FT4: Thyroxine; TPO: Thyroid peroxidase; HIV: Human immunodeficiency virus; HCV: Hepatitis C virus; ANA: Antinuclear antibody; MPO: Myeloperoxidase; RF: Rheumatoid factor; CEA: Carcinoembryonic antigen; AFP: Alpha fetoprotein; CA: Cancer antigen.